risperidone has been researched along with trifluoperazine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Baldy, WJ; Barrett, DL; DiStefano, DL; Elgin, RJ; Fedde, CL; Kesslick, JM; Kukla, MJ; Martin, GE; Mathiasen, JR; Scott, MK | 1 |
| Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mahmood, T; Silverstone, T | 1 |
| Dryden-Edwards, RC; Reiss, AL | 1 |
| Collins, SP; Mendes, LS | 1 |
| Shiwach, RS; Woods, S | 1 |
| Bäumer, D; Ebert, D; Tebartz van Elst, L; Trimble, MR | 1 |
| Danilov, DS; Tiul'pin, IuG | 1 |
| Edimansyah, A; Liew, A; Subramaniam, M; Vaingankar, J; Verma, S | 1 |
| Lee, J; Ng, KW; Swapna, V | 1 |
| Chan, HY; Chen, CH; Chen, JJ; Gau, SS; Hwu, HG | 1 |
| Bond, AJ; Chan, CK; Chan, F; Pang, AH; Tse, WS; Wong, AS | 1 |
| Aung-Din, D; Feldman, SR; Jorizzo, JL; Sahni, DR | 1 |
| Chithra, NK; Sreeraj, VS; Suhas, S; Venkatasubramanian, G | 1 |
| Osman, E; Yıldız, M | 1 |
2 review(s) available for risperidone and trifluoperazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Morgellons disease: insights into treatment.
Topics: Anti-Bacterial Agents; Antipsychotic Agents; Humans; Medication Adherence; Morgellons Disease; Physician-Patient Relations; Risperidone; Trifluoperazine; Wound Infection | 2018 |
1 trial(s) available for risperidone and trifluoperazine
| Article | Year |
|---|---|
Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Single-Blind Method; Trifluoperazine | 2012 |
18 other study(ies) available for risperidone and trifluoperazine
| Article | Year |
|---|---|
Pyrrole mannich bases as potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Male; Mannich Bases; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship | 1992 |
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comments on "Clozapine treatment after agranulocytosis induced by classic neuroleptics".
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Haloperidol; Humans; Male; Risperidone; Schizophrenia; Trifluoperazine | 1996 |
Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Hallucinations; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Risperidone; Sertraline; Trifluoperazine | 1996 |
The effects of the atypical antipsychotics clozapine, remoxipride and risperidone on the contractile characteristics of rat skeletal muscle in vitro.
Topics: Animals; Antipsychotic Agents; Caffeine; Clozapine; Dantrolene; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Halothane; In Vitro Techniques; Muscle Contraction; Muscle Relaxants, Central; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Remoxipride; Risperidone; Trifluoperazine | 1997 |
Risperidol and withdrawal bruxism in Lewy body dementia.
Topics: Aged; Antipsychotic Agents; Bruxism; Delusions; Dopamine Antagonists; Humans; Male; Parkinson Disease; Risperidone; Substance Withdrawal Syndrome; Thiothixene; Trifluoperazine | 1998 |
Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia.
Topics: Amygdala; Antipsychotic Agents; Brain; Clopenthixol; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Factor Analysis, Statistical; Flupenthixol; Haloperidol; Hippocampus; Humans; Psychotic Disorders; Risperidone; Schizophrenia; Trifluoperazine | 2004 |
[Prescription of traditional neuroleptics in the remission period for schizophrenic patients with excess of body mass caused by atypical antipsychotics].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Drug Prescriptions; Female; Follow-Up Studies; Haloperidol; Humans; Male; Mental Status Schedule; Olanzapine; Overweight; Risperidone; Schizophrenia; Treatment Outcome; Trifluoperazine | 2007 |
Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders.
Topics: Adolescent; Adult; Antipsychotic Agents; Asian People; Female; Haloperidol; Humans; Kaplan-Meier Estimate; Male; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Schizophrenia; Socioeconomic Factors; Treatment Outcome; Trifluoperazine; Young Adult | 2010 |
Management of a patient with schizophrenia and underlying pituitary macroadenoma.
Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bromocriptine; Dopamine Antagonists; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Pituitary Neoplasms; Quinolones; Risperidone; Schizophrenia; Serotonin Antagonists; Trifluoperazine | 2010 |
Different mechanisms of risperidone result in improved interpersonal trust, social engagement and cooperative behavior in patients with schizophrenia compared to trifluoperazine.
Topics: Antipsychotic Agents; Humans; Interpersonal Relations; Risperidone; Schizophrenia; Social Skills; Treatment Outcome; Trifluoperazine; Trust | 2016 |
Clinical utility of trifluoperazine in the treatment of obsessive-compulsive disorder: A case report.
Topics: Humans; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Trifluoperazine | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |